Chemed To Report Fourth-Quarter 2024 Earnings February 26, Related Conference Call To Be Held On February 27
Chemed (NYSE: CHE) has announced it will release its fourth-quarter 2024 financial results on February 26, 2025, after the NYSE trading close. The company will host a conference call and webcast on February 27, 2025, at 10 a.m. ET to discuss quarterly results and provide a business update.
Participants can access the event through Chemed's investor relations website or via teleconference registration. A replay will be available approximately two hours after the call through the company's website.
Chemed operates two main subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States.
Chemed (NYSE: CHE) ha annunciato che pubblicherà i risultati finanziari del quarto trimestre 2024 il 26 febbraio 2025, dopo la chiusura del mercato NYSE. L'azienda organizzerà una teleconferenza e una trasmissione web il 27 febbraio 2025 alle 10:00 ET per discutere i risultati trimestrali e fornire un aggiornamento aziendale.
I partecipanti possono accedere all'evento attraverso il sito web delle relazioni con gli investitori di Chemed o registrandosi alla teleconferenza. Una registrazione sarà disponibile circa due ore dopo la chiamata attraverso il sito web dell'azienda.
Chemed opera attraverso due principali sussidiarie: VITAS Healthcare, il più grande fornitore nazionale di cure hospice di fine vita, e Roto-Rooter, il principale fornitore di servizi di idraulica e pulizia dei drenaggi negli Stati Uniti.
Chemed (NYSE: CHE) ha anunciado que publicará sus resultados financieros del cuarto trimestre de 2024 el 26 de febrero de 2025, después del cierre de la bolsa NYSE. La empresa llevará a cabo una conferencia telefónica y web el 27 de febrero de 2025 a las 10 a.m. ET para discutir los resultados trimestrales y proporcionar una actualización del negocio.
Los participantes pueden acceder al evento a través del sitio web de relaciones con inversores de Chemed o mediante el registro de teleconferencia. Una repetición estará disponible aproximadamente dos horas después de la llamada a través del sitio web de la empresa.
Chemed opera dos subsidiarias principales: VITAS Healthcare, el proveedor más grande del país de cuidados hospice al final de la vida, y Roto-Rooter, el proveedor líder de servicios de fontanería y limpieza de desagües en los Estados Unidos.
Chemed (NYSE: CHE)는 2025년 2월 26일, 뉴욕 증권 거래소 거래 마감 후에 2024년 4분기 재무 결과를 발표할 것이라고 발표했습니다. 회사는 2025년 2월 27일 오전 10시 ET에 분기 결과를 논의하고 사업 업데이트를 제공하기 위한 컨퍼런스 콜 및 웹캐스트를 개최할 예정입니다.
참가자는 Chemed의 투자자 관계 웹사이트를 통해 또는 전화 회의 등록을 통해 이벤트에 접근할 수 있습니다. 통화 후 약 2시간 후에 회사의 웹사이트에서 재생을 이용할 수 있습니다.
Chemed는 두 개의 주요 자회사를 운영합니다: VITAS Healthcare, 미국 내 생애 말기 호스피스 치료의 최대 공급자, 그리고 Roto-Rooter, 미국에서 배관 및 배수 청소 서비스의 선두 공급자입니다.
Chemed (NYSE: CHE) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre 2024 le 26 février 2025, après la fermeture de la Bourse NYSE. L'entreprise organisera une conférence téléphonique et un webinaire le 27 février 2025 à 10 heures ET pour discuter des résultats trimestriels et fournir une mise à jour sur l'entreprise.
Les participants peuvent accéder à l'événement via le site web des relations investisseurs de Chemed ou en s'inscrivant à la téléconférence. Une rediffusion sera disponible environ deux heures après l'appel sur le site web de l'entreprise.
Chemed exploite deux filiales principales : VITAS Healthcare, le plus grand fournisseur de soins d'hospice de fin de vie aux États-Unis, et Roto-Rooter, le principal fournisseur de services de plomberie et de nettoyage des drains aux États-Unis.
Chemed (NYSE: CHE) hat angekündigt, dass die Finanzzahlen für das vierte Quartal 2024 am 26. Februar 2025 nach Börsenschluss veröffentlicht werden. Das Unternehmen wird am 27. Februar 2025 um 10 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um die Quartalsergebnisse zu besprechen und ein Unternehmensupdate zu geben.
Die Teilnehmer können über die Investor-Relations-Website von Chemed oder über die Registrierung für die Telefonkonferenz auf die Veranstaltung zugreifen. Eine Wiederholung wird etwa zwei Stunden nach dem Anruf über die Website des Unternehmens verfügbar sein.
Chemed betreibt zwei Haupttochtergesellschaften: VITAS Healthcare, den größten Anbieter von Hospizdiensten für das Lebensende im Land, und Roto-Rooter, den führenden Anbieter von Sanitär- und Abflussreinigungsdiensten in den Vereinigten Staaten.
- None.
- None.
Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, February 27, 2025, to discuss the company's quarterly results and to provide an update on its business.
Participants may access a live webcast of the conference call through the investor relations section of Chemed’s website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/pxs2dghv/.
Participants may also register via teleconference at: https://register.vevent.com/register/BIa60a1e9fbd7b47dab63b5406c1e907a2.
Once registration is completed, participants will be provided with a dial-in number containing a personalized conference code to access the call. All participants are instructed to dial-in 15 minutes prior to the start time.
A taped replay of the conference call will be available beginning approximately two hours after the call's conclusion. You may access the replay via webcast through the investors relations section of Chemed’s website.
Listed on the New York Stock Exchange and headquartered in
Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250211613136/en/
Michael D. Witzeman
(513) 762-6714
Source: Chemed Corporation
FAQ
When will Chemed (CHE) release Q4 2024 earnings?
How can investors access Chemed's (CHE) Q4 2024 earnings call?
What time is Chemed's (CHE) Q4 2024 earnings conference call?
What are Chemed's (CHE) main business segments?
